Developed by Bayer, vardenafil is a potent PDE5 inhibitor approved for erectile dysfunction (ED) treatment in 2002. It selectively targets PDE5 in the corpus cavernosum, enhancing cGMP levels to promote erections. Clinical studies have shown that it improves erectile function regardless of the severity or cause of ED, including in men with diabetes and post-radical prostatectomy. Vardenafil is rapidly absorbed and can produce erections within 16 minutes, making it a fast-acting oral therapy. It has a lower risk of vision-related side effects compared to sildenafil due to its greater PDE5 selectivity .
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Valitra 20 by Pharmaceutical Grade, consult with your doctor or healthcare professional.
Home
